ID   HML-2 [Human leukemia]
AC   CVCL_RL97
DR   Cosmic; 787434
DR   Wikidata; Q54889936
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9444944;
CC   Population: Japanese.
CC   Characteristics: CSF2 and KITLG dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL96 ! HML
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9444944; DOI=10.1016/S0145-2126(97)00086-6;
RA   Kamijo, Takehiko
RA   Koike, Kenichi
RA   Takeuchi, Kouichi
RA   Higuchi, Tsukasa
RA   Sawai, Nobukuni
RA   Kikuchi, Toshimi
RA   Tsumura, Haruhiko
RA   Akiyama, Hirokazu
RA   Koike, Tadashi
RA   Ishii, Eizaburo
RA   Komiyama, Atsushi
RT   "Analysis of synergism between stem cell factor and
RT   granulocyte-macrophage colony-stimulating factor on human
RT   megakaryoblastic cells: an increase in tyrosine phosphorylation of 145
RT   kDa subunit of c-kit in two-factor combination.";
RL   Leuk. Res. 21:1097-1106(1997).
//